Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|September 2, 2005
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsL J Mu, J A Kyte, G Kvalheim, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 20, 1992
[Infection problems in the leukopenia phase after autologous bone marrow transplantation]L Rusten, S O Kvaløy, E Jakobsen, et al.Blood|November 1, 1994
All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cellsE B Smeland, L Rusten, S E Jacobsen, et al.Breast Cancer Research and Treatment|September 20, 2001
Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patientsK S Hall, T Wiklund, B Erikstein, et al.Scandinavian Journal of Immunology|September 3, 2011
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times dailyD Torfoss, B Sandstad, T E Mollnes, et al.Journal of Hematotherapy|April 1, 1997
Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral bloodB Naume, E Borgen, K Beiske, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancerG Wiedswang, E Borgen, R Kåresen, et al.Cancer Gene Therapy|May 20, 2006
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNAJ A Kyte, L Mu, S Aamdal, et al.Leukemia|August 1, 1992
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cellsE B Smeland, S Funderud, G Kvalheim, et al.Gene Therapy|February 6, 2015
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse modelH Almåsbak, E Walseng, A Kristian, et al.Pageof 7